Clinical features of patients with HCC who are negative for both HBV and HCV markers

被引:0
|
作者
Watabe, H [1 ]
Shiratori, Y [1 ]
Tateishi, R [1 ]
Fujishima, T [1 ]
Akamatsu, M [1 ]
Koike, Y [1 ]
Obi, S [1 ]
Hamamura, K [1 ]
Sato, S [1 ]
Teratani, T [1 ]
Shiina, S [1 ]
Omata, M [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan
关键词
hepatitis B; hepatitis C; hepatocellular carcinoma; liver function; alcohol; antibody to the hepatitis B core antigen; cirrhosis;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The aim of this study is to clarify the clinical features of hepatocellular carcinoma that are negative for both hepatitis B surface antigen and anti-hepatitis C antibody. Methodology: Patients were classified according to viral markers: 45 patients (8%) had hepatitis B (B-HCC), 467 patients (82%) had hepatitis C (C-HCC), and 53 patients (9%) had neither hepatitis B nor hepatitis C (NBNC-HCC). Differences in clinical parameters among these three groups were analyzed. Results: Patients with NBNC-HCC were older than B-HCC and C-HCC patients. The incidence of alcoholism in NBNC-HCC patients was higher than in C-HCC patients. Patients with NBNC-HCC had similar rates of positive antibody to hepatitis B core antigen as did patients with C-HCC. NBNC-HCC patients were further classified according to median age. The younger group showed a greater tendency towards alcoholism than did the aged group. Liver functioning in the younger group was worse than in the older. group. The older group had larger tumors than the younger group. Conclusions: The livers of younger NBNC-HCC patients were more cirrhotic, possibly because of alcoholism. Older NBNC-HCC patients presented with larger tumors, possibly because they did not receive regular medical check-ups due to their relatively preserved liver function.
引用
收藏
页码:2157 / 2160
页数:4
相关论文
共 50 条
  • [21] HBV and HCV infections in relation to the chosen genetic features in hemodialyzed patients
    Urbanowicz, W
    Wawrzynowicz-Syczewska, M
    Boron-Kaczmarska, A
    NEPHRON, 2000, 85 (04): : 357 - 357
  • [22] Incidence of hepatocellular carcinoma (HCC) in HCV, HBV and both virus related cirrhosis: A 13 years prospective study.
    Vian, A
    Conti, S
    Lorenzoni, U
    Ntakirutimana, E
    Floreani, A
    Stroffolini, T
    Naccarato, R
    Chiaramonte, M
    HEPATOLOGY, 1996, 23 (01) : P261 - P261
  • [23] Incidence of hepatocellular carcinoma (HCC) in HCV, HBV and both virus related cirrhosis: A 15 years prospective study.
    Vian, A
    Stazi, MA
    Lorenzoni, U
    Lobello, S
    Floreani, A
    Stroffolini, T
    Naccarato, R
    Chiaramonte, M
    HEPATOLOGY, 1997, 26 (04) : 1338 - 1338
  • [24] Effect of HBV Exposure on Clinical Outcomes among HCV-Positive Patients Who Undergo Liver Transplantation
    Limketkai, Berkeley
    Gurakar, Ahmet
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S96 - S96
  • [25] The clinical features of patients with advanced HCC treated with sorafenib who experienced long-term survival
    Sawada, Koji
    Abe, Masami
    Saito, Yoshinori
    Hasebe, Takumu
    Nakajima, Shunsuke
    Ohtake, Takaaki
    Hasebe, Chitomi
    Fuiya, Mikihiro
    Kohgo, Yutaka
    ANNALS OF ONCOLOGY, 2015, 26 : 111 - 111
  • [26] Distinct clinical and genetic characteristics of AFP-negative hepatocellular carcinoma patients infected by HBV or HCV.
    Zhang, Bixiang
    Duan, Jingxian
    Li, Yingmei
    Ding, Zeyang
    Zhang, Zhanguo
    Chen, Shifu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] PREVALENCE OF HBV, HDV AND HCV HEPATITIS MARKERS IN HIV-POSITIVE PATIENTS
    FRANCISCI, D
    BALDELLI, F
    PAPILI, R
    STAGNI, G
    PAULUZZI, S
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1995, 11 (02) : 123 - 126
  • [28] PREVALENCE OF HBV AND HCV INFECTION MARKERS AMONG PATIENTS WITH 2 TYPE DIABETES
    Savvin, R. G.
    Maximova, S. S.
    YAKUT MEDICAL JOURNAL, 2013, (04): : 21 - 29
  • [29] Serum markers for early diagnosis of HCC in HCV cirrhotic patients with SVR to DAA treatment
    Sangiovanni, A.
    D'Ambrosio, R.
    Lunghi, G.
    Bruccoleri, M.
    Alimenti, E.
    Borghi, M.
    Perbellini, R.
    Aghemo, A.
    Iavarone, M.
    Colombo, M.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E47 - E47
  • [30] PRIMARY LIVER-CANCER IN HBSAG NEGATIVE PATIENTS IS ASSOCIATED TO THE PERSISTENCE OF BOTH HBV AND HCV GENOMES IN SERUM AND TUMOR-TISSUES
    PATERLINI, P
    FRANCO, D
    DRISS, F
    NALPAS, B
    PISI, E
    BERTHELOT, P
    BRECHOT, C
    HEPATOLOGY, 1991, 14 (04) : A215 - A215